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Abstract
Background: Immunosuppressive viruses are frequently found as co-infections in the chicken industry, potentially
causing serious economic losses. Because traditional molecular biology methods have limited detection ability, a
rapid, high-throughput method for the differential diagnosis of these viruses is needed. The objective of this study
is to develop a GenomeLab Gene Expression Profiler Analyser-based multiplex PCR method (GeXP-multiplex PCR)
for simultaneous detection of eight immunosuppressive chicken viruses.
Results: Using chimeric primers, eight such viruses, including Marek's disease virus (MDV), three subgroups of avian
leucosis virus (ALV-A/B/J), reticuloendotheliosis virus (REV), infectious bursal disease virus (IBDV), chicken infectious
anaemia virus (CIAV) and avian reovirus (ARV), were amplified and identified by their respective amplicon sizes. The
specificity and sensitivity of the optimised GeXP-multiplex PCR assay were evaluated, and the data demonstrated that
this technique could selectively amplify these eight viruses at a sensitivity of 100 copies/20 μl when all eight viruses
were present. Among 300 examined clinical specimens, 190 were found to be positive for immunosuppressive viruses
according to this novel assay.
Conclusion: The GeXP-multiplex PCR assay is a high-throughput, sensitive and specific method for the
detection of eight immunosuppressive viruses and can be used for differential diagnosis and molecular
epidemiological surveys.
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Background
Immunosuppression causes major economic losses in
poultry farming because immunosuppressed chickens
are more susceptible to viral and bacterial pathogens, re-
spond poorly to vaccination, and display lower feed con-
version efficiency as well as growth retardation.
Immunosuppressive chicken viruses include Marek’s dis-
ease virus (MDV), avian leucosis virus (ALV), reticuloen-
dotheliosis virus (REV), infectious bursal disease virus
(IBDV), chicken infectious anaemia virus (CIAV) and
avian reovirus (ARV), all of which affect immune func-
tion in chickens and lead to immunosuppression [1–7].
The typical symptoms elicited by these viruses differ,
and some symptoms are not readily observable.
Immunosuppression in chickens infected with MDV,
ALV or REV occurs much earlier than does tumour de-
velopment and death [1, 2]. Although early infection
with IBDV in chicks less than 3 weeks old may not re-
sult in the typical symptoms of IBD, this infection none-
theless causes serious immunosuppression [8]. Chickens
older than 3 weeks of age are resistant to anaemia after
infection with CIAV yet remain susceptible to immuno-
suppression [9]. Furthermore, the possibility of co-
infection makes it difficult to differentiate among these
immunosuppressive viruses [10–13].
The detection and differential diagnosis of immunosup-
pressive viruses are important for the poultry industry.
However, conventional methods, such as virus isolation
and serum neutralisation tests, are typically time-
consuming and labour-intensive procedures [14]. Molecu-
lar methods have been used to rapidly detect immunosup-
pression in chickens, but they are limited by their ability
* Correspondence: xiezhixun@126.com
Guangxi Key Laboratory of Animal Vaccines and Diagnostics, Guangxi
Veterinary Research Institute, 51 Youai North Road, Nanning, Guangxi
530001, China
© 2015 Zeng et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zeng et al. Virology Journal  (2015) 12:226 
DOI 10.1186/s12985-015-0455-5
to detect only a few pathogens per reaction [15–20].
Therefore, a rapid, cost-effective, and high-throughput de-
tection technique is needed for the clinical diagnosis of
immunosuppressive viral infection in chickens.
The GenomeLab Gene Expression Profiler genetic ana-
lysis system (GeXP) is a new multi-target, high-
throughput detection platform that integrates RT-PCR or
PCR with a labelled, amplified product in a multiplex RT-
PCR/PCR assay followed by fluorescence capillary electro-
phoresis separation based on the sizes of the amplified
products [21]. The GeXP profiler utilises gene-specific
primers containing 5′-universal adaptor sequences [21]:
the chimeric primers consist of a universal sequence fused
to the 5′-end of a gene-specific sequence. The forward
primer consists of a universal dye-labelled sequence fused
to the 5′-end of a gene-specific sequence, whereas the re-
verse primer consists of a universal unlabelled sequence
fused to the 5′-end of a gene-specific sequence. Products
differing by 7–10 bp in size are separated by capillary elec-
trophoresis. This technique has been used to identify vari-
ous diseases in humans, including 11 genotypes of HPV
[22]; 9 serotypes of hand, foot, and mouth disease [23];
cancer [21, 24]; 7 enteric viruses [25]; and H1N1 [26]. The
GeXP genetic analysis system has also been successfully
utilised to simultaneously detect 9 avian respiratory patho-
gens in clinical samples, 8 swine reproductive and respira-
tory pathogens and 11 duck viruses [27–29].
In this study, a GeXP-multiplex PCR assay was devel-
oped and optimised to simultaneously detect eight im-
munosuppressive chicken viruses: MDV, ALV (three
subgroups of ALV, ALV-A/B/J), REV, IBDV, CIAV and
ARV.
Results
Specificity of the GeXP-multiplex PCR assay
The concentrations of the GeXP-multiplex PCR-specific
primers (listed in Table 1) were optimised, and DNA/
cDNA from the immunosuppressive viruses described in
Table 2 was used individually as a template for evaluat-
ing the specificity of the GeXP-multiplex PCR assay.
The expected size of each immunosuppressive viral
amplicon was determined. A single peak for the complex
PCR was detected using the GeXP analyser system (Fig. 1
a-i), and no mispriming with or non-specific amplifica-
tion of other avian pathogens or the chicken genome
was observed.
Sensitivity of the GeXP-PCR assay
The GeXP-multiplex PCR assay achieved the following
minimum sensitivity levels in the detection of each of
the eight detectable immunosuppressive viruses using
eight sets of primers and either plasmid or in vitro
ssRNA transcripts: 10 copies for the ALV-A, ALV-J,
REV, CIAV and ARV viruses; and 100 copies for the
MDV, ALV-B and IBDV viruses (electropherograms not
shown). Tenfold serial dilutions of specific DNA-
containing plasmids and in vitro ssRNA transcripts from
the eight immunosuppressive viruses, i.e., 105 (Fig. 2a),
104 (Fig. 2b), 103 (Fig. 2c) and 102 (Fig. 2d) copies per
reaction, were prepared and amplified using an equal
amount of template. When all of the pre-mixed, specific
DNA-containing plasmids and in vitro ssRNA tran-
scripts corresponding to the eight immunosuppressive
viruses were present, the GeXP-multiplex PCR assay
achieved a minimum sensitivity of 100 copies.
Artificial mixtures and interference assays
To test the differentiation ability of the GeXP-multiplex
PCR assay, samples previously deemed positive for avian
immunosuppressive viruses were randomly mixed;
DNA/RNA was then extracted, and the appropriate spe-
cific amplification peaks were observed (Fig. 3). When
either ARV and IBDV or ALV-J and ALV-B were mixed,
two specific amplification peaks were observed (ARV,
216.16 bp; IBDV, 294.55 bp; ALV-J, 203.93 bp; and ALV-
B, 284.83 bp), and when DNA/cDNA from all eight im-
munosuppressive viruses was mixed, eight specific amp-
lification peaks were observed (ALV-A, 155.37 bp; REV,
182.69 bp; ALV-J, 203.71 bp; ARV, 216.01 bp; MDV,
227.49 bp; CIAV, 268.60 bp; ALV-B, 284.65 bp; and
IBDV, 294.55 bp).
Specific amplification peaks were also observed when
107 copies of ALV-J, 102 copies of MDV and 103 copies of
CIAV were mixed in a single reaction, and similar amplifi-
cation peaks were observed when 107 copies of ALV-J or
102 copies of MDV were individually tested (Fig. 4). These
results demonstrate minimal to no interference by mixed
infections in the GeXP-multiplex PCR assay.
Evaluation of the GeXP-PCR assay using clinical
specimens
A total of 300 clinical specimens were collected from
diseased farm chickens and tested using the GeXP-
multiplex PCR assay. The chickens ranged from 50 to
135 days old, and the cohort included layer, broiler and
breeding birds. The results of the GeXP-multiplex PCR
assay are provided in Table 3. Independent real-time
PCR/RT-PCR and sequencing to identify true positives
and negatives confirmed the GeXP-multiplex PCR re-
sults, with the positive results being 100 % comparable
to those for real-time PCR/RT-PCR and sequencing.
Among a total of 190 positive results, 119 specimens
displayed a single infection with an immunosuppressive
virus. A total of 110 specimens were negative for the
eight immunosuppressive viruses. A Kappa value of 1
was found with regard to consistency among GeXP-
multiplex PCR, real-time PCR/RT-PCR and sequencing
results.
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Table 1 Primer sequences and PCR product sizes






MDV AGGTGACACTATAGAATAAGGGAGCAGACGTACTATGTAGACAA GTACGACTCACTATAGGGATGGTAAGCAGTCCAAGGGTCA 227 meq 0.16
ALV-A AGGTGACACTATAGAATACAAGGGGTTCCTTGGTATCT GTACGACTCACTATAGGGATGTGCCTATCCGCTGTCA 155 gp85 0.2
ALV-B AGGTGACACTATAGAATATCAATCACGATTCTCCCACC GTACGACTCACTATAGGGATGTGACGCTTCGTTTACGTCTT 285 gp85 0.2
ALV-J AGGTGACACTATAGAATACTGATGCAACAACCAGGAAA GTACGACTCACTATAGGGAGCAGTAACATTAGTGACATACCC 204 gp85 0.2
REV AGGTGACACTATAGAATAGACCAGGCGAGCAAAATC GTACGACTCACTATAGGGAGGTGTAATAGGTAGGTATGGAGGA 182 gp90 0.2
IBDV AGGTGACACTATAGAATAGGGTCAGGGCTAATTGTCTT GTACGACTCACTATAGGGATCTGTCAGTTCACTCAGGCTTC 294 VP2 0.2
CIAV AGGTGACACTATAGAATAAAAGGCGAACAACCGATGA GTACGACTCACTATAGGGATGCCCTGGAGGAAAAGACC 269 VP1 0.2
ARV AGGTGACACTATAGAATAGGACCCCTACTTCTGTTCTCA GTACGACTCACTATAGGGAATTTCCCGTGGACGACAT 215 S1 0.16
Universal primers AGGTGACACTATAGAATA GTACGACTCACTATAGGGA 0.25










MDV, ALV (three subgroups found predominantly in
China, ALV-A/B/J), REV, IBDV, CIAV and ARV are
the major immunosuppressive viruses causing eco-
nomic losses to the chicken industry. Furthermore,
the possibility of co-infection increases the difficulty
of differentially diagnosing individual viral infections
[16, 30–33]. However, conventional diagnostic
methods are time consuming, and molecular methods
are limited by their ability to detect only a few patho-
gens per reaction.
The advantages of the GeXP-multiplex PCR assay in-
clude its specificity and its high-throughput ability to
differentiate eight immunosuppressive viruses. These ad-
vantages stem from the use of chimeric and universal
primers in a 3-step PCR procedure with different an-
nealing temperatures: the first step amplifies gene-
specific sequences within specific regions of the chimeric
primers; the second step utilises the entire chimeric pri-
mer; and the last step uses universal primers for amplifi-
cation. As non-specific amplification is minimised by
using chimeric primers in the second step at a
temperature 13 °C higher than the temperature in step
one, only specific amplicons are produced. Furthermore,
false-positive reactions are minimised via capillary elec-
trophoresis separation to confirm the identity of the
bands [21]. Based on electropherograms, amplicon sizes
were found to deviate from their theoretical size by ap-
proximately +/-1 bp; for example, amplicons of 154–
156 bp indicated a positive result for ALV-A. In contrast,
conventional multiplex PCR and multiplex real-time
PCR are able to identify only two to four pathogens in
one reaction [16, 34–36].
Another advantage of this GeXP-multiplex PCR assay
is improved detection sensitivity [27]. In this study, the
minimum detection limit of the GeXP-multiplex PCR
assay was 100 copies (DNA plasmids or in vitro ssRNA
transcripts) for all mixed templates, and the minimum
absorbance unit (A.U.) was 9000; by default, a reaction
was considered positive when A.U. >2000. Further evalu-
ation of clinical specimens confirmed that the positive
results were 100 % comparable to the results of
sequencing.
The third advantage of this GeXP-multiplex PCR assay
is the ability to avoid interference due to the use of uni-
versal primers in the last step, ensuring equal amplifica-
tion efficiency of each target gene, regardless of
differences in pathogen concentration.
Table 2 Sources of pathogens
Pathogen Source Pathogen Source
Reference viruses Other viruses
Marek’s disease virus KC453972, KC453973, GX130112, GX140301, 050118, 070123, 090201,
100428
GVRI Inactivated H5N1 avian influenza
virus Re-1
HVRI
Avian leucosis virus subgroup A isolate RSV-1 CVCC Avian influenza virus H9N6/Duck/
HK/147/77
HKU
Avian leucosis virus subgroup A isolate GX110521, GX110522, ALVA01, ALVA02, ALVA03 GVRI Avian influenza virus H7N2/chicken
PA/3979/97
PU
Avian leucosis virus subgroup B isolate RSV-2 CVCC Newcastle disease virus F48E9 GVRI
Avian leucosis virus subgroup B isolate GX111230, GX130401, ALVB15, ALVB23, ALVB28 GVRI Newcastle disease virus GX6/02 GVRI
Avian leucosis virus subgroup J isolate KC453974, KC453975, GX090201, GX090521, GX110110,
GX120081, GX130018, GX140010
GVRI Infectious bronchitis virus
Massachusetts 41
GVRI
Reticuloendotheliosis virus AV235 CVCC Infectious laryngotracheitis virus
AV1231
CIVDC
Reticuloendotheliosis virus KC453976, KC453977, GX120825, GX131118 GVRI Mycoplasma synoviae CAU0748 CVCC
Avian reovirus S1133, 1733, 526, C78, GuangxiR1, GuangxiR2, GX110058 GVRI
Infectious bursal disease virus CA, AV162, AV144 CVCC
Infectious bursal disease virus AV6 CIVDC
Infectious bursal disease virus 070124, 080113, 090053, 100008, 110110, 130223 GVRI
Chicken infectious anaemia virus CAU0728, CAU0729, CAU0730, CAU0731, CAU0732 CVCC
Chicken infectious anaemia virus GXC060821 GVRI
a) HVRI = Harbin Veterinary Research Institute, China
b) HKU = The University of Hong Kong, China
c) GVRI = Guangxi Veterinary Research Institute, China
d) CIVDC = China Institute of Veterinary Drug Control, China
e) PU = University of Pennsylvania
f) CVCC = China Veterinary Culture Collection Centre
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Fig. 1 (See legend on next page.)
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Of the viruses evaluated in this study, MDV and CIAV
are DNA viruses, and IBDV, ALV, REV and ARV are
RNA viruses. ALV and REV are retroviruses, which in-
sert their proviral DNA into the host genome for viral
replication [37]. In these cases, we recommend using a
DNA/RNA kit to extract DNA/RNA together, followed
by the procedure described above. All of these immuno-
suppressive viruses affect the immune organs of chick-
ens, including the thymus, spleen and bursa, and these
organs should be collected from diseased chickens for
diagnosis.
An analysis of 300 specimens using the GeXP-multiplex
PCR assay revealed MDV as the most prevalent single in-
fection, followed by ARV. MDV +ALV-J was the most
prevalent co-infection, yet different co-infections were
also present. Our data demonstrate that MDV and ALV-J
are the main pathogens that co-infect with other immuno-
suppressive viruses and that various co-infections are
common in chickens in south China. Chickens infected
with one immunosuppressive virus are more susceptible
to attack by another immunosuppressive virus, and
vaccine contamination might be a cause of common
co-infections [38, 39].
As no assay can be 100 % accurate, there are some
limitations to this assay. Virus genomes vary; thus, some
primers will likely not be suitable for future use, and
additional primers may be required for different varia-
tions. Furthermore, the GeXP instrument is expensive
for clinical applications; therefore, the availability of less
expensive machines will be important.
(See figure on previous page.)
Fig. 1 GeXP-multiplex PCR assay specificity. The GeXP-multiplex PCR assay was performed using a single template and mixed primers for the
following: ALV-A: 155.38 bp (a); ALV-B: 284.65 bp (b); ALV-J: 204.55 bp (c); MDV: 227.35 bp (d); REV: 182.64 bp (e); CIAV: 268.61 bp (f); ARV:
215.83 bp (g); IBDV: 294.27 bp (h). DNA from the thymus, spleen and bursa of SPF chickens was used as a negative control (I). The x axes
represent the sizes of PCR products in bp, and the y axes represent the dye signal in absorbance units (A.U.). Blue peaks denote specific
amplification peaks, and red peaks denote marker peaks
Fig. 2 GeXP-multiplex PCR assay sensitivity. The GeXP-multiplex PCR assay was performed with mixed primers using equal amounts of specific
DNA-containing plasmid template and in vitro-transcribed ssRNA corresponding to eight immunosuppressive viruses at concentrations of 105 (a),
104 (b), 103 (c) or 102 (d) copies per reaction. The x axes represent the sizes of PCR products in bp, and the y axes represent the dye signal in
absorbance units (A.U.)
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Fig. 3 Artificially mixed templates for the GeXP-multiplex PCR assay. The GeXP-multiplex PCR assay was performed using artificially mixed templates
and mixed primers for ARV and IBDV (a), ALV-J and ALV-B (b), or eight immunosuppressive viruses (c). The x axes represent the sizes of PCR products
in bp, and the y axes represent the dye signal in absorbance units (A.U.)
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Fig. 4 GeXP-multiplex PCR interference assays. The GeXP-multiplex PCR assay was performed using templates for ALV-J, MDV and CIAV (a), MDV
(b), or ALV-J (c). The x axes represent the sizes of PCR products in bp, and the y axes represent the dye signal in absorbance units (A.U.)
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Conclusion
In conclusion, the GeXP-multiplex PCR assay is a high-
throughput, sensitive and specific method for detecting
eight immunosuppressive viruses in chickens. Accord-
ingly, this assay is a potentially useful tool for the detec-
tion and differentiation of immunosuppressive viruses
and for molecular epidemiologic testing, especially in sit-
uations in which chicken flocks are not performing well
and the underlying cause may be immunosuppressive vi-
ruses. Identifying the immunosuppressive viruses re-
sponsible for these infections will be helpful for
designing better disease-control programmes.
Methods
Ethics statement
This study was approved by the Animal Care and Use
Committee (IACUC) of the Guangxi Veterinary Re-
search Institute. Specimen collection from diseased
chickens and SPF chickens, the use of chicken embryo
fibroblasts (CEFs) and the collection of allantoic fluid
from SPF chicken embryos were performed in accord-
ance with the IACUC protocol to minimise animal
suffering. The CEFs and embryos were then used for
virus propagation.
Viruses and clinical specimens
MDV, ALV (three subgroups of ALV, A/B/J), REV, IBDV,
CIAV, ARV and the other viruses used in this study are
listed in Table 2. MDV, ALV-A/B/J, and REV were prop-
agated in chicken embryo fibroblasts (CEFs), and IBDV
and ARV were propagated in SPF chicken embryos.
CIAV was propagated using a homogenate of positive
samples of chicken liver and bone marrow to infect SPF
1-day-old broilers, from which the bone marrow was
collected at 10 days after infection. Clinical tissue speci-
mens of the thymus, bursa, spleen, bone marrow, blood
and liver were collected from diseased chickens at
poultry farms.
RNA/DNA extraction and RNA reverse transcription
MDV DNA from infected CEFs, CIAV DNA from the
bone marrow of affected chickens, REV and ALV-A/B/J
genomic proviral DNA from infected CEFs, and IBDV
and ARV RNA from allantoic fluid were extracted using
the E.Z.N.A.® Total DNA/RNA Isolation Kit (OMEGA,




















MDV 26 8.7 % 26 26 1 (p < 0.001) MDV +
ALV-A
4 1.3 % 4 4 1 (p < 0.001)
ALV-
A
6 2.0 % 6 6 1 (p < 0.001) MDV +
ALV-J
25 8.3 % 25 25 1 (p < 0.001)
ALV-
B
2 0.7 % 2 2 1 (p < 0.001) ALV-B +
ALV-J
1 0.4 % 1 1 1 (p < 0.001)
ALV-
J
21 7.0 % 21 21 1 (p < 0.001) MDV +
ALV-J +
REV
6 2 % 6 6 1 (p < 0.001)
REV 15 5 % 15 15 1 (p < 0.001) MDV +
CIAV
5 1.6 % 5 5 1 (p < 0.001)
IBDV 17 5.7 % 17 17 1 (p < 0.001) MDV +
REV
6 2 % 6 6 1 (p < 0.001)
CIAV 9 3 % 9 9 1 (p < 0.001) ALV-J +
REV
3 1.5 % 3 3 1 (p < 0.001)
ARV 23 7.7 % 23 23 1 (p < 0.001) IBDV +
ALV-J




4 1.3 % 4 4 1 (p < 0.001)
REV +
ARV
3 1 % 3 3 1 (p < 0.001)
ALV-J +
ARV
6 2 % 6 6 1 (p < 0.001)
ALV-J +
IBDV
3 1 % 3 3 1 (p < 0.001)
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Norcross, GA, USA). The extracted DNA/RNA was
eluted in DNase- and RNase-free dH2O and stored at
−80 °C. The RNA was used to generate cDNA via re-
verse transcription, as described previously [36].
GeXP-multiplex PCR primer design
Gene-specific primers were designed based on sequence
information obtained from GenBank using Primer prem-
ier 5.0 software (Premier, Palo Alto, USA) and NCBI
Primer-Blast. ALV-A/B/J primers were designed to cor-
respond to a specific region of the envelope gene gp85,
MDV primers to a specific region of the gene encoding
Marek’s EcoRI-Q protein (meq), REV primers to a spe-
cific region of the envelope gene gp90, IBDV primers to
a specific region of the capsid protein gene VP2, CIAV
primers to a specific region of the capsid protein gene
VP1, and ARV primers to a specific region of the S1
gene. The primer sequences, the sizes of the resulting
amplicons, and the target regions are listed in Table 2.
The chimeric primers consisted of a universal sequence
fused to the 5′-end of a gene-specific sequence. The for-
ward universal primer was labelled at the 5′-end with
the fluorescent dye Cy5. All chimeric primers and uni-
versal primers were synthesised and purified by poly-
acrylamide gel electrophoresis (Invitrogen, Shanghai,
China).
GeXP-multiplex PCR assay
GeXP-multiplex PCR assays were performed using the
Genome Lab GeXP Starter Kit (Beckman Coulter, Brea,
USA) in a 20-μl volume containing 4 μl of 5× buffer,
0.25 μM (final concentration) universal forward and re-
verse primers, 2 μl of MgCl2 (25 μM), 1 μl of chimeric
primer mixture, 0.35 μl of Thermo-Start DNA polymer-
ase, 1 μl of cDNA/DNA, and nuclease-free H2O. The
concentration of the chimeric primers was optimised ac-
cording to the amplification efficiency of the GeXP-
multiplex PCR assay.
The GeXP-multiplex PCR assay was performed via a
three-step amplification procedure after a 5-min incuba-
tion at 95 °C: 10 cycles of 30 s at 94 °C, 30 s at 55 °C, and
30 s at 72 °C; 10 cycles of 30 s at 94 °C, 30 s at 68 °C, and
30 s at 72 °C; 20 cycles of 30 s at 94 °C, 30 s at
50 °C, and 30 s at 72 °C; and 5 min at 72 °C. The
reactions were then held at 4 °C in the thermal cy-
cler (Thermo, Milford, USA).
Separation by capillary electrophoresis and fragment
analysis
After amplification, 1 μl of PCR product was added to
38.75 μl of sample loading solution along with 0.25 μl of
DNA size standard 400 (Beckman Coulter, Brea, USA).
The fluorescently labelled amplicons were separated into
distinct peaks on a electropherogram via GeXP high-
resolution capillary electrophoresis and then identified by
their respective sizes. The dye signal strength of each peak
was measured in A.U. of optical fluorescence and was de-
fined as the fluorescence signal minus the background sig-
nal. The data were imported into the analysis module of
eXpress Profiler software (Beckman Coulter, Brea, USA)
as a tab-delimited file for subsequent analyses.
Specificity and sensitivity of the GeXP-multiplex PCR
assay
The assay specificity for each immunosuppressive viral
target was individually tested with a mixture of 8 sets of
chimeric primers in a multiplex PCR assay after opti-
misation. Other conventional chicken viruses, including
the H5/H7/H9 serotypes of avian influenza virus (AIV),
Newcastle disease virus (NDV), infectious bronchitis
virus (IBV) and infectious laryngotracheitis virus (ILTV),
were used as negative controls. DNA from the thymus,
spleen and bursa of SPF chickens was also used as a
negative control.
Specific PCR amplicons for each virus were individu-
ally cloned into the pGEM-T vector (Promega, Madison,
USA), and the plasmids were purified and sequenced.
The sequence data were analysed and compared with
the corresponding sequence data in GenBank. The IBDV
and ARV plasmids were linearised with SpeI (Takara,
Dalian, China) and then in vitro transcribed into ssRNA
using the RiboMAXLarge Scale RNA Production Sys-
tems SP6/T7 Kit (Promega, Madison, USA). After
DNase I digestion, ssRNA was purified with TRIzol
(Invitrogen, Shanghai, China) and chloroform. The con-
centration of plasmid DNA and transcribed ssRNA was
measured at 260 nm using a NanoDrop 2000 (Thermo
Fisher Scientific, Waltham, USA), and the copy number
was calculated [40]. Plasmid DNA and transcribed
ssRNA were diluted to a final concentration ranging
from 105 copies/μl to 1 copy/μl and then subjected to
the GeXP-multiplex PCR assay with 8 sets of chimeric
primers, both individually and in pre-mixed solutions.
The sensitivity of the GeXP-multiplex PCR assay was re-
evaluated three times on three different days.
Artificial mixture and interference assays
To simulate co-infection, thymus, spleen, bursa, bone
marrow, blood and liver samples from chickens previ-
ously diagnosed with the immunosuppressive viruses
were randomly chosen and mixed together in various
amounts; DNA/RNA was then extracted. cDNA was
generated from RNA as described above. GeXP-
multiplex PCR assays were performed using the mixed
DNA/cDNA.
Different concentrations of specific DNA-containing
plasmids and in vitro ssRNA transcripts (107 copies/μl
to 102 copies/μl) were used as templates for GeXP-
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multiplex PCR assays to evaluate interference, and the
results were compared with those of single-template
GeXP-multiplex PCR assays.
Evaluation of the GeXP-multiplex PCR assay with clinical
specimens
A total of 300 clinical specimens, including the thymus
gland, spleen, bursa, bone marrow, blood and liver of
diseased chickens, were collected from farms. These dis-
eased chickens showed various symptoms, with most
exhibiting depression and anepithymia and some show-
ing extreme emaciation. One-third of the diseased chick-
ens were diarrheic, and approximately half showed
respiratory symptoms; some chickens displayed both
diarrhea and respiratory symptoms. Approximately one-
fourth of the diseased chickens exhibited a poor reaction
to vaccination or was prone to bacterial infection. Mor-
tality ranged from 2 % to 30 %. Tumours in the liver,
heart, spleen or skin were observed in only approxi-
mately 20 chickens and not always in those showing ex-
treme emaciation.
DNA/RNA was extracted, and RNA was reverse tran-
scribed as described above. The GeXP-multiplex PCR
assay was performed using DNA/cDNA as the template,
and the results were confirmed using independent real-
time PCR/RT-PCR and sequencing to determine true
positives. Independent real-time PCR/RT-PCR was per-
formed using the primers described above but without
the universal sequence at the 5′-end. The results of
GeXP-multiplex PCR, real-time PCR/RT-PCR and se-
quencing were analysed by the Kappa statistical method
using SPSS software (IBM, New York, USA).
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